Novel Drug Delivery Systems for Cancer Therapy Market by Technology (Embolization Particles – Drug Eluting Beads, Polyvinyl Alcohol Particles, Microspheres, Gelatin-Based Embolization Devices, Selective Internal Radiation Therapy, Holmium-Based Microspheres; Liquid Embolics – Onyx (LES and HD-500), TRUFILL nBCA LES; Nanoparticles, and Forecast 2026-2034
$3,000.00
Report Specifications
Novel drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. The novel drug delivery systems minimize drug degradation and loss, prevent harmful side-effects and increase drug bioavailability and the fraction of the drug accumulated in the required zone.
A large variety of embolic agents are used by interventional radiologists for the selective occlusion of arteries supplying blood to tumors which depends on various factors including size of the vessel to be embolized, duration of the vessel to be occluded, desired clinical outcome and also the intrinsic properties and behavior of the agent.
The global novel drug delivery systems for cancer therapy market report provides market size ($million 2024 to 2034), market share and forecast (CAGR%, 2026 to 2034).
The global novel drug delivery systems for cancer therapy market segmentation based on technology such as embolization particles – drug eluting beads, Polyvinyl Alcohol particles, microspheres, gelatin-based embolization devices, selective internal radiation therapy (SIRT/ Radioembolization), Holmium-based microspheres; Liquid Embolics – Onyx (LES and HD-500), TRUFILL nBCA LES; and nanoparticles.
The global novel drug delivery systems for cancer therapy market research report divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
The global novel drug delivery systems for cancer therapy market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.
Major players operating in the global novel drug delivery systems for cancer therapy market and included in this report are Advanced Medical Isotope Corporation, Boston Scientific Corporation (BTG plc), CeloNova Biosciences, Inc., Cook Medical, Inc., Cospheric LLC, Eckert & Ziegler BEBIG, Kobo Products, Inc., Medtronic plc (Covidien plc), Merit Medical Systems, Inc., Mo-Sci Corporation, Nanobiotix, Pfizer, Inc. (Bind Therapeutics), Polysciences, Inc., Sirtex Medical, Inc. and Terumo Corporation.
DATA INCLUDED: Novel Drug Delivery Systems for Cancer Therapy Market Size, Novel Drug Delivery Systems for Cancer Therapy Market Share, Novel Drug Delivery Systems for Cancer Therapy Market Growth Rates, Novel Drug Delivery Systems for Cancer Therapy Market Trends, and Novel Drug Delivery Systems for Cancer Therapy Market Forecast to 2034
Market Data:
- Base Year Estimation: 2025
- Historical Data Range: 2024-2025
- Forecast Period: 2026-2034
- Market Representation: Revenue in $million and CAGR % from 2026 to 2034
- Regional Scope: North America, Europe, Asia Pacific, Latin America, Rest of the World (Middle East & Africa)
- Country Scope: U.S., Canada, U.K., Germany, France, Italy, Spain, Japan, China, India, South Korea, Brazil, Mexico, South Africa, South Korea, Saudi Arabia, UAE, and other countries.
- Report Coverage: Revenue forecasts, company market share, competitive landscape analysis, growth factors, and market trends
- Customization Scope (15% Free): Accommodation of specific or custom requirements beyond the current report scope.
Qualitative Analysis:
- Industry Overview
- Industry Trends
- Market Driver, Restraints, and Opportunities
- Market Size
- Growth Trends
- Market Profitability Analysis
- Market Attractiveness Matrix
- Competitive Landscape
- Company Overview
- Financial Performance
- Product Portfolio
- Strategic Insights
- Recent Developments
Quantitative Analysis:
- Market Size Projections: Comprehensive estimates and forecasts for all segments
- Regional Market Analysis: Estimates and forecasts for key countries
- Corporate Financial Performance: Analysis of company financials
- Competitive Landscape: Market share analysis of leading companies
For inquiries regarding discounts on single or bundled report purchases, please reach out to us.
- Introduction
- Executive Summary
- Market Size Estimation ($million, 2024-2034)
- Forecast Estimation ($million and CAGR%, 2026-2034)
- Research Methodology
- Market Landscape
- Market Dynamics
- Drivers
- Barriers
- Opportunities
- Market Share Analysis
- Companies
- Devices
- Market Trends Analysis
- Key success factors
- Market Growth Rate
- Market Attractiveness Analysis
- Market Profitability Analysis
- Buyer power
- Supplier power
- Barriers to entry
- Threat of substitute products
- Rivalry among firms in the industry
- Distribution Channels
- Market Dynamics
- Market Segmentation [refer Market Segments and Companies Tab]
- Device or Brand Type
- Diagnostic Test
- Indication Type
- Technology
- Diagnostics, Therapeutic or Surgical Application
- End User Groups
- Geography (Region, Country)
- North America (U.S., Canada)
- Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
- Asia Pacific (Japan, China, India, Rest of APAC)
- Latin America (Brazil, Mexico, Rest of LA)
- Rest of the World (Middle East & Africa)
- Regulatory Overview
- Device Classification I, II, III, IV
- Device (FDA, EMEA) Approvals
- Company Profiles [refer Market Segments and Companies Tab]
- Company Overview
- Financial Snapshot
- Product Portfolio
- Business Strategies
- Recent Developments
- Recommendations
- References
Key Questions Answered:
1. What are the factors driving and limiting this market, key success factors and challenges?
2. Which are the leading competitors in the market, their market share, profitability and key trends by product, technology, services portfolio?
3. How do markets perform between countries and regions?
4. What market segments are contributing to maximum share and greatest growth?
5. What is the product or procedure volumes by country and regions?
Actionable Insights Included:
1. Product portfolio matrix (Share vs. Growth)
2. Market attractiveness (Region vs. Growth)
3. Spot matrix (Product vs. Region)
4. Geographic distribution matrix (Share vs. Growth)
Novel Drug Delivery Systems for Cancer Therapy Market
1. Technology
1.1 Embolization Particles
1.1.1. Drug Eluting Beads
1.1.2. Polyvinyl Alcohol (PVA) Particles
1.1.3 Microspheres
1.1.4 Gelatin-Based Embolization Devices
1.1.5. Selective Internal Radiation Therapy (SIRT)/ Radioembolization
1.1.6. Holmium-based Microspheres
1.2 Liquid Embolics
1.2.1. Onyx (LES and HD-500)
1.2.2. TRUFILL nBCA LES
1.3. Nanoparticles
2. Geography (Region, Country)
2.1. North America (U.S., Canada)
2.2. Latin America (Brazil, Mexico, Rest of LA)
2.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4. Asia Pacific (Japan, China, India, Rest of APAC)
2.5. Rest of the World
3. Company Profiles
3.1. Advanced Medical Isotope Corporation
3.2. Boston Scientific Corporation (BTG plc)
3.3. CeloNova BioSciences, Inc.
3.4. Cook Medical, Inc.
3.5. Cospheric LLC
3.6. Eckert & Ziegler BEBIG
3.7. Kobo Products, Inc.
3.8. Medtronic plc (Covidien plc)
3.9. Merit Medical Systems, Inc.
3.10. Mo-Sci Corporation
3.11. Nanobiotix
3.12. Polysciences, Inc.
3.13. Sirtex Medical, Inc.
3.14. Terumo Corporation
Related Reports
-

Osteosynthesis Devices Market and Forecast 2026-2034
$3,000.00 -

Cardiopulmonary Stress Testing Devices Market and Forecast 2026-2034
$3,000.00 -

Bone Grafts and Substitutes Market and Forecast 2026-2034
$3,000.00 -

Contrast Media Injectors Market and Forecast 2026-2034
$3,000.00 -

Ultrasound Devices Market and Forecast 2026-2034
$3,000.00 -

Blood Flow Measurement Devices Market and Forecast 2026-2034
$3,000.00 -

Blood Pressure Monitoring Devices Market and Forecast 2026-2034
$3,000.00 -

Cardiac Pacemakers Market and Forecast 2026-2034
$3,000.00